Actions

Newsfeed Popular Local Discover Follows Blocks Bookmarks Filters Settings PowerUps Help Updates

zacks.com / Share Newsitem

View, share or embed this newsitem using the details below.

Zacks Investment Research: Stock Research, Analysis, & Recommendations

@zacks.com/10 hours10h

APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA

Applied Therapeutics stock surges 69% as the FDA says that no advisory committee meeting is required to discuss the govorestat NDA for classic galactosemia.

https://newsreadery.com/go/f34955b1b4f04c6afab25716eb69a298

Save

Back

Read Full Article